Gourt > Health > Pharmacy > Drugs and Medications > A > Amineptine
Amineptine (Maneon® (Italy), Survector® (Spain, Italy, Philippines) is an atypical tricyclic antidepressant that selectively inhibits the reuptake of dopamine and to a lesser extent norepinephrine, thus exerting a powerful and fast-acting antidepressant effect.
Introduced in France in 1978 by the pharmaceutical giant Servier and marketed under the trade name Survector®, amineptine soon gained a reputation for abuse due to its short-lived, but pleasant, stimulant effect experienced by some patients. (This is to be distinguished from its antidepressant effect, which appears in approximately 7 days after commencing treatment.) This led to the Food and Drug Administration suspending the marketing authorisation for Survector® in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until 2005.
Currently amineptine is off-patent and very difficult to obtain. Rare cases of hepatotoxicity, some serious, have been reported, but these were thought to be due to a genetic predisposition.
More on [ Amineptine ]
WL Issued to Oncology Tech, LLP
FDA Fri, 27 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Oncology Tech, LLP on 27 Jun 2008 by Dallas District Office
WL Issued to Mostel, Edward, M.D.
FDA Fri, 16 May 2008 00:00:00 -0400
FDA Warning Letter Issued to Mostel, Edward, M.D. on 16 May 2008 by Center for Drug Evaluation and Research
WL Issued to Merck & Company, Inc.
FDA Mon, 28 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Merck & Company, Inc. on 28 Apr 2008 by Office of Enforcement
WL Issued to Blood Center of New Jersey
FDA Tue, 15 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Blood Center of New Jersey on 15 Apr 2008 by New Jersey District Office
WL Issued to Asfora, Wilson T. M.D.
FDA Mon, 07 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Asfora, Wilson T. M.D. on 07 Apr 2008 by Center for Devices and Radiological Health
WL Issued to Philips Medical Systems, Inc
FDA Tue, 01 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Philips Medical Systems, Inc on 01 Apr 2008 by Cincinnati District Office
CFDA: FDA Latest Drug GCP Warning Letters
WL Issued to Husain, Mustafa M, M.D.
FDA Wed, 23 Jul 2008 00:00:00 -0400
FDA Warning Letter Issued to Husain, Mustafa M, M.D. on 23 Jul 2008 by Center for Devices and Radiological Health
WL Issued to Bowers, James H. Jr., M.D.
FDA Tue, 08 Jul 2008 00:00:00 -0400
FDA Warning Letter Issued to Bowers, James H. Jr., M.D. on 08 Jul 2008 by Center for Devices and Radiological Health
WL Issued to Travanti Pharma, Inc.
FDA Mon, 30 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Travanti Pharma, Inc. on 30 Jun 2008 by Center for Drug Evaluation and Research
WL Issued to Ponugoti, Nagarjuna R., M.D.
FDA Fri, 06 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Ponugoti, Nagarjuna R., M.D. on 06 Jun 2008 by Center for Drug Evaluation and Research
WL Issued to Hamlin, Charles M.D.
FDA Mon, 02 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Hamlin, Charles M.D. on 02 Jun 2008 by Center for Devices and Radiological Health
WL Issued to Synapse Biomedical Inc.
FDA Sun, 01 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Synapse Biomedical Inc. on 01 Jun 2008 by Center for Devices and Radiological Health
Amineptine (Survector): The Smart Tricyclic - Short overview, describing this drug as a mild stimulant and a fast-acting mood-brightener.
Meta Description: [ Amineptine ( Survector ) is a mild but pleasant stimulant and a fast-acting mood-brightener ]
Erowid Amineptine (Survector) Vault - Information about this drug, including pharmacology, abuse potential, side effects and withdrawal systems, and reasons it was removed from the market in many countries.
Meta Description: [ Information about Amineptine (Survector) ]
